文献詳細
連載 今月の話題
文献概要
黄斑部毛細血管拡張症は特発性に片眼性あるいは両眼性に黄斑部の網膜毛細血管拡張所見を呈する疾患群の総称であり,Yannuzziらは臨床所見により3つのサブタイプに分類している。しかしそれらのサブタイプは背景に存在する病態から考えておのおの全く異なる疾患といっても過言ではない。本稿では黄斑部毛細血管拡張症の正確な確定診断のために必要な事項および現状での治療戦略につき概説する。
参考文献
1)Gass JD, Blodi BA:Idiopathic juxtafoveolar retinal telangiectasis:update of classification and follow-up study. Ophthalmology 100:1536-1546, 1993
2)Yannuzzi LA, Bardal AM, Freund KB et al:Idiopathic macular telangiectasia. Arch Ophthalmol 124:450-460, 2006
3)Li KK, Goh TY, Parsons H et al:Use of intravitreal triamcinolone acetonide injection in unilateral idiopathic juxtafoveal telangiectasis. Clin Experiment Ophthalmol 33:542-544, 2005
4)Gamulescu MA, Walter A, Sachs H et al:Bevacizumab in the treatment of idiopathic macular telangiectasia. Graefes Arch Clin Exp Ophthalmol 246:1189-1193, 2008
5)Koizumi H, Iida T, Maruko I:Morphologic features of group 2A idiopathic juxtafoveolar retinal telangiectasis in three-dimensional optical coherence tomography. Am J Ophthalmol 142:340-343, 2006
6)Gaudric A, Ducos de Lahitte G et al:Optical coherence tomography in group 2A idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol 124:1410-1419, 2006
7)Paunescu LA, Ko TH, Duker JS et al:Idiopathic juxtafoveal retinal telangiectasis:new findings by ultrahigh-resolution optical coherence tomography. Ophthalmology 113:48-57, 2006
8)Maruko I, Iida T, Sekiryu T et al:Early morphological changes and functional abnormalities in group 2A idiopathic juxtafoveolar retinal telangiectasis using spectral domain optical coherence tomography and microperimetry. Br J Ophthalmol 92:1488-1491, 2008
9)Koizumi H, Slakter JS, Spaide RF:Full-thickness macular hole formation in idiopathic parafoveal telangiectasis. Retina 27:473-476, 2007
10)Koizumi H, Cooney MJ, Leys A et al:Centripetal retinal capillary proliferation in idiopathic parafoveolar telangiectasis. Br J Ophthalmol 91:1719-1720, 2007
11)Powner MB, Gillies MC, Tretiach M et al:Perifoveal muller cell depletion in a case of macular telangiectasia type 2. Ophthalmology 117:2407-2416, 2010
12)Charbel Issa P, Finger RP, Holz FG et al:Eighteen-month follow-up of intravitreal bevacizumab in type 2 idiopathic macular telangiectasia. Br J Ophthalmol 92:941-945, 2008
13)Mandal S, Venkatesh P, Abbas Z et al:Intravitreal bevacizumab(Avastin)for subretinal neovascularization secondary to type 2A idiopathic juxtafoveal telangiectasia. Graefes Arch Clin Exp Ophthalmol 245:1825-1829, 2007
掲載誌情報